Stefan Schönland
- Molecular Biology top 1%
- Genetics top 0.5%
- Oncology top 2%
- Hematology top 0.5%
- Nephrology top 0.2%
- Co-authors
- Ute HegenbartGiampaolo MerliniGiovanni PalladiniAnthony D. HoArnt V. KristenPhilip N. HawkinsHartmut GoldschmidtChristoph Kimmich
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (169 papers)Multiple Myeloma Research and Treatments (52 papers)Parathyroid Disorders and Treatments (24 papers)
- Cited by
- NephrologyGeneticsHematology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Stefan Schönland
208 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 5.9k
- Genetics 1.6k
- Oncology 1.5k
- Hematology 1.5k
- Nephrology 1.4k
Countries citing papers authored by Stefan Schönland
This map shows the geographic impact of Stefan Schönland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Schönland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Schönland more than expected).
Fields of papers citing papers by Stefan Schönland
This network shows the impact of papers produced by Stefan Schönland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Schönland. The network helps show where Stefan Schönland may publish in the future.
Co-authorship network of co-authors of Stefan Schönland
This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Schönland. A scholar is included among the top collaborators of Stefan Schönland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Schönland. Stefan Schönland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 13 | |
| 10 | 46 | |
| 11 | 27 | |
| 12 | 83 | |
| 13 | 56 | |
| 14 | 9 | |
| 15 | 61 | |
| 16 | 12 | |
| 17 | 101 | |
| 18 | HOVON 104; FINAL RESULTS FROM A MULTICENTER, PROSPECTIVE PHASE II STUDY OF BORTEZOMIB BASED INDUCTION TREATMENT FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH DE NOVO AL AMYLOIDOSIS | 1 |
| 19 | 147 | |
| 20 | 99 |
About Stefan Schönland
Stefan Schönland is a scholar working on Hematology, Genetics and Nephrology, having authored 222 papers that have together received 7.2k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (169 papers), Multiple Myeloma Research and Treatments (52 papers) and Parathyroid Disorders and Treatments (24 papers). The work is most often cited by research in Nephrology (1.4k citations), Genetics (1.6k citations) and Hematology (1.5k citations). Stefan Schönland has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Ute Hegenbart, Giampaolo Merlini, Giovanni Palladini, Anthony D. Ho, Arnt V. Kristen, Philip N. Hawkins, Hartmut Goldschmidt, Christoph Kimmich, Morie A. Gertz and Angela Dispenzieri. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.